Recapitulation of Clinical Individual Susceptibility to Drug-Induced QT Prolongation in Healthy Subjects Using iPSC-Derived Cardiomyocytes

To predict drug-induced serious adverse events (SAE) in clinical trials, a model using a panel of cells derived from human induced pluripotent stem cells (hiPSCs) of individuals with different susceptibilities could facilitate major advancements in translational research in terms of safety and pharm...

Descripción completa

Detalles Bibliográficos
Autores principales: Shinozawa, Tadahiro, Nakamura, Koki, Shoji, Masanobu, Morita, Maya, Kimura, Maya, Furukawa, Hatsue, Ueda, Hiroki, Shiramoto, Masanari, Matsuguma, Kyoko, Kaji, Yoshikazu, Ikushima, Ippei, Yono, Makoto, Liou, Shyh-Yuh, Nagai, Hirofumi, Nakanishi, Atsushi, Yamamoto, Keiji, Izumo, Seigo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312248/
https://www.ncbi.nlm.nih.gov/pubmed/28111276
http://dx.doi.org/10.1016/j.stemcr.2016.12.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312248/
https://www.ncbi.nlm.nih.gov/pubmed/28111276
http://dx.doi.org/10.1016/j.stemcr.2016.12.014

Ejemplares similares